CCND1 and breast carcinoma: To further elucidate the mechanism of Cyclin D1 upregulation, the levels of Cyclin D1 protein in parental and resistant breast cancer cells were examined when cycloheximide (CHX) or MG132 was used to inhibit de novo protein synthesis or proteasome degradation respectively.